Cromwell Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.2K Sell
538
-827
-61% -$55.1K 0.02% 530
2026
Q1
$85.7K Buy
1,365
+863
+172% +$60.1K 0.05% 363
2025
Q4
$33.3K Sell
502
-881
-64% -$57K 0.02% 520
2025
Q3
$93.1K Hold
1,383
0.05% 331
2025
Q2
$121K Buy
1,383
+232
+20% +$18.2K 0.07% 268
2025
Q1
$78.6K Sell
1,151
-169
-13% -$13.8K 0.05% 340
2024
Q4
$103K Buy
1,320
+945
+252% +$70K 0.06% 283
2024
Q3
$25.1K Sell
375
-766
-67% -$62.9K 0.02% 556
2024
Q2
$129K Buy
+1,141
New +$144K 0.08% 225

Other funds holding DXCM

Cromwell Holdings's DXCM Position: Q2 2026 in Review

Cromwell Holdings reduced its DexCom (DXCM) stake by 61% in Q2 2026, selling an estimated $55.1K and leaving 538 shares worth $36.2K. The position accounts for 0.02% of the portfolio, ranked #530.

Cromwell Holdings first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $129K in Q2 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cromwell Holdings held 538 shares of DexCom worth $36.2K as of Q2 2026.
  • Cromwell Holdings sold 827 DexCom shares in Q2 2026, an estimated $55.1K.
  • DexCom made up 0.02% of Cromwell Holdings's portfolio in Q2 2026, its #530 holding.
  • Cromwell Holdings first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's DexCom position peaked at $129K in Q2 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.